comparemela.com

Latest Breaking News On - Karun krishna - Page 2 : comparemela.com

AstraZeneca's Arun Krishna says Tagrisso-based combo promises new option in lung cancer

Jack O’Brien interviews AstraZeneca’s Arun Krishna about a Tagrisso-based combo that promises a new option in lung cancer. Plus, updates on the new NIH director and the latest TikTok trend.

United-states
America
Jack-obrien
Karun-krishna
Lecia-bushak
Monica-bertagnolli
Astrazeneca
Jacko-brien
President-biden

Indians in World War | The Calcutta boy who took on the Japanese, Germans in the skies during WWII

The story of Karun Krishna ‘Jumbo’ Majumdar, the Bengali pilot who played pivotal roles in history-altering victories in Asia and Europe

Calcutta
West-bengal
India
United-kingdom
New-zealand
Taungoo
Obago
Myanmar
Germany
Shaan
Kachin-state
Falaise

Healthcare sector is big priority for Kerala industry: Minister Rajeeve

Healthcare sector is big priority for Kerala industry: Minister Rajeeve
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Kerala
India
Kanpur
Uttar-pradesh
Trithvam-integris
Kironb-reddy
Karun-krishna
Kerala-mission
Kerala-medical-technology-consortium
Facebook
Association-of-diagnostics-manufacturers-india
Blockchain-technology

A kidney for Vishnu: Atlanta resident in urgent need of a donor

Vishnu Dureddy lives in Suwanee with his wife Pushpa Dureddy and his two daughters aged 15 and 13. An IT professional, he continues to work from home. Pushpa serves as a physical therapist.

South-carolina
United-states
India
Houston
Texas
Bangalore
Karnataka
Charleston
Karun-krishna
Vishnu-dureddy
Pushpa-dureddy
Vikram-reddy-kunchala

LYNPARZA (olaparib) APPROVED IN GREAT BRITAIN AS ADJUVANT TREATMENT FOR PATIENTS WITH GERMLINE BRCA-MUTATED HER2-NEGATIVE HIGH-RISK EARLY BREAST CANCER

STRICTLY EMBARGOED UNTIL Tuesday 6 September 2022 00:01 BST LYNPARZA (olaparib) APPROVED IN GREAT BRITAIN AS ADJUVANT TREATMENT FOR PATIENTS WITH GERMLINE BRCA-MUTATED HER2-NEGATIVE HIGH-RISK EARLY BREAST CANCER First and only approved medicine in Great Britain which targets germline BRCA mutations in pati.

United-kingdom
London
City-of
Great-britain
British
Karun-krishna
Andrew-tutt
Ptom-keith-roach
King-college-london
Astrazeneca
Institute-of-cancer-research
Cancer-research-united-kingdom

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.